James Sapirstein

Affiliations

  • Director at Onconetix Inc. (ONCO), 2024-09-30
  • Director at Zyversa Therapeutics Inc. (ZVSA), 2024-07-19
  • Chairman And Ceo at Entero Therapeutics Inc. (ENTO), 2024-07-03
  • Director at Renovaro Inc. (RENB), 2024-06-27
  • Interim Ceo at Marizyme Inc (MRZM), 2021-03-23
  • Director at Blue Water Acquisition Corp. (BLUW), 2020-12-16
  • Chief Executive Officer at Contravir Pharmaceuticals Inc. (CTRV), 2018-01-05
  • Director at Respirerx Pharmaceuticals Inc. (RSPI), 2017-12-13
  • Director at Probility Media Corp (PBYA), 2017-02-15
  • Ceo, Therapeutics Division at Alliqua Inc. (ALQA), 2014-01-17
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
CTRV $1.00 10,000 $10,000.00 13,000 2016-02-18 Filing
CTRV $2.15 500 $1,075.00 3,000 2015-11-30 Filing
CTRV $1.64 2,500 $4,100.00 2,500 2015-11-23 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ENTO $1.07 1,289 $1,379.23 35,816 2024-07-02 Filing
FWBI $4.23 174 $735.92 37,105 2024-04-01 Filing
FWBI $4.96 1,887 $9,359.52 37,279 2024-03-15 Filing
FWBI $4.20 166 $697.20 39,166 2024-01-12 Filing
FWBI $0.29 2,764 $801.56 33,397 2023-10-04 Filing